| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.14 | 0.007 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.008 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.008 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.099 | 0.008 |